LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr | ₹1,136 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹2,390 Cr |
Mar2024 | ₹820 Cr |
Mar2023 | ₹992 Cr |
Mar2022 | ₹1,153 Cr |
Mar2021 | ₹1,136 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,390 Cr | 191.57 | |
Mar2024 | ₹820 Cr | -17.38 | |
Mar2023 | ₹992 Cr | -13.96 | |
Mar2022 | ₹1,153 Cr | 1.50 | |
Mar2021 | ₹1,136 Cr | - |
Compare Total Non-Current Liabilities of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹87,739.9 Cr | -4.2% | 1% | -11.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | -4.2% |
1% |
-11.4% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses